Blindness News and Research RSS Feed - Blindness News and Research

Latest online version of German Diabetes Risk Score optimized for mobile devices

Latest online version of German Diabetes Risk Score optimized for mobile devices

The German Institute of Human Nutrition has updated the online version of its German Diabetes Risk Score and has optimized it for mobile devices. [More]
Study estimates real-world prevalence of myopic choroidal neovascularization in the U.S.

Study estimates real-world prevalence of myopic choroidal neovascularization in the U.S.

A new study estimates that 9.6 million adults in the United States are highly myopic, or severely nearsighted. Of those, nearly 820,000 have a degenerative form of the disease and more than 41,000 suffer a complication called myopic choroidal neovascularization that could cause long-term vision loss, with women at higher risk. [More]
Delayed healing linked to weaker electrical currents in diabetic wounds

Delayed healing linked to weaker electrical currents in diabetic wounds

People with diabetes often suffer from wounds that are slow to heal and can lead to ulcers, gangrene and amputation. New research from an international group led by Min Zhao, professor of ophthalmology and of dermatology at the University of California, Davis, shows that, in animal models of diabetes, slow healing is associated with weaker electrical currents in wounds. [More]
Researchers develop new method to combat VR sickness

Researchers develop new method to combat VR sickness

Columbia Engineering Professor Steven K. Feiner and Ajoy Fernandes MS'16 have developed a method of combating virtual reality (VR) sickness that can be applied to consumer head-worn VR displays, such as the Oculus Rift, HTC Vive, Sony PlayStation VR, and Google Cardboard. [More]
Darapladib drug can protect against vision loss in diabetic patients

Darapladib drug can protect against vision loss in diabetic patients

Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness. [More]
Scientists identify gene linked to severe glaucoma in children

Scientists identify gene linked to severe glaucoma in children

Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children. [More]
Scientists developing cost-effective retinal scanner for early diagnosis of glaucoma, diabetic retinopathy

Scientists developing cost-effective retinal scanner for early diagnosis of glaucoma, diabetic retinopathy

A European group of scientists are working on the development of a breakthrough, compact, cost-effective retinal scanner that will play a key role in targeting the early diagnosis of retinal diseases that are worldwide leading causes of blindness. [More]
Controlling corneal blindness by 2030: an interview with Dr Pravin Vaddavalli

Controlling corneal blindness by 2030: an interview with Dr Pravin Vaddavalli

Corneal blindness is estimated to be the second most prevalent cause of blindness in many less developed countries. Globally, bilateral corneal blindness is estimated to afflict 4.9 million persons and accounts for 12% of 39 million blind, utilizing WHO 2010 global blindness data. [More]
Dishwasher and laundry capsules pose threat to children

Dishwasher and laundry capsules pose threat to children

Parents are being warned of the major health risks of children mistaking potentially harmful dishwasher and laundry capsules for sweets, after figures showed at least one case is happening every day. [More]
New study identifies PDGFRα as key molecule for HCMV viral entry

New study identifies PDGFRα as key molecule for HCMV viral entry

A publication in the scientific journal Nature Microbiology identifies PDGFRα as the receptor for the trimeric gHgLgO complex of Human cytomegalovirus (HCMV). [More]
Few commercial weight loss programs show promise of benefit for diabetic patients

Few commercial weight loss programs show promise of benefit for diabetic patients

Johns Hopkins scientists who indirectly investigated the blood sugar effects of 10 (out of 32 selected) commercial weight loss programs say a few show promise of benefit for diabetic patients, but far more rigorous research is needed before doctors can wholeheartedly recommend them. [More]
Vision Express advises Britons to be 'sun safe' when choosing eyewear

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed. [More]
Zika virus infection may cause ocular problems in Brazilian infants with microcephaly

Zika virus infection may cause ocular problems in Brazilian infants with microcephaly

Researchers studying babies with a Zika virus-related birth defect say they have found previously unreported eye problems possibly linked to the virus that could result in severe visual impairment. [More]
NIH-funded study finds visual impairment, blindness may double by 2050

NIH-funded study finds visual impairment, blindness may double by 2050

With the youngest of the baby boomers hitting 65 by 2029, the number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data and from studies funded by the National Eye Institute, part of the National Institutes of Health. [More]
Researchers use high-power prisms to design new eyeglasses to expand visual fields of hemianopia patients

Researchers use high-power prisms to design new eyeglasses to expand visual fields of hemianopia patients

Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear and Harvard Medical School have designed three new eyeglasses using high-power prisms to optimally expand the visual fields of patients with hemianopia, a condition in which the visual fields of both eyes are cut by half. [More]
Potential new intraocular treatment based on RAS manipulation can prevent or reverse diabetic retinopathy

Potential new intraocular treatment based on RAS manipulation can prevent or reverse diabetic retinopathy

Pathologic changes of the retina caused by diabetes is the leading cause of blindness in working adults. Diabetic retinopathy has no known cure, treatment options are inadequate, and prevention strategies offer limited protection. In the first of its kind, a report in The American Journal of Pathology describes a potential new intraocular treatment based on manipulating the renin angiotensin system (RAS) that both prevents and reverses some characteristics of diabetic retinopathy in a mouse model. [More]
New study shows Ebola survivors may be at risk of severe vision loss

New study shows Ebola survivors may be at risk of severe vision loss

A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash. [More]
LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

The University of Southern California Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD) in the National Eye Institute-funded "Los Angeles Latino Eye Study." The study, published in JAMA Ophthalmology, is the first to analyze the risk and prevalence of early and late stage AMD and its impact on quality of life for older Latinos. [More]
NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries. [More]
Scientists find way to reduce need for secondary cataract surgery

Scientists find way to reduce need for secondary cataract surgery

Scientists at the University of East Anglia may have found a way to prevent complications from surgery to treat cataract - the world's leading cause of blindness. [More]
Advertisement
Advertisement